Lundbeck Canada Offers New Treatment Option for Relapsed Indolent B-cell ... R & D Magazine "For some patients with CLL, Treanda could result in much longer remission periods compared with chlorambucil. And for some patients with iNHL whose cancer has progressed after treatment with rituximab, Treanda could help reduce their cancer burden." ... |
